Association of PON2 variation with birth weight in Trinidadian neonates of South Asian ancestry

Pharmacogenetics

Volumn 9, Issue 3, 1999, Pages 351-356

  Busch, Christopher P ^a   Dan Ramdath, D ^b   Ramsewak, Samuel ^c   Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b Biochemistry Unit   (Trinidad and Tobago)

^c UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Complex traits; Diabetes; Metabolism; Oxidation

Indexed keywords

ARYLDIALKYLPHOSPHATASE;

ARTICLE; ASIAN; BIRTH WEIGHT; CONTROLLED STUDY; ETHNIC GROUP; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; TRINIDAD AND TOBAGO;

EID: 0032768060     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199906000-00010     Document Type: Article

References (35)

1. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 8663:577-580.
2. Barker DJP, Osmond C, Simmonds SJ, Wield GA. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. Br Med J 1993; 306:422-426.
3. Barker DJP. The fetal and infant origins of disease. Eur J Clin Invest 1995; 25:457-463.
4. Beckles GLA, Miller GJ, Kirkwood BR, Alexis SD, Carson DC, Byam NTA. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1986; 8493:1298-1301.
5. Boright AP, Connelly PW, Brunt JH, Scherer SW, Tsui LC, Hegele RA. Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites. Atherosclerosis 1998; 139:131-136.
6. Dhawan J. Coronary heart disease risks in Asian Indians. Curr Opin Lipidol 1996; 7:196-198.
7. Dunger DB, Ong KKL, Huxtable SJ, Sherriff A, Woods KA, Ahmed ML, et al. Association of the INS VNTR with size at birth. Nature Genet 1998; 19:98-100.
8. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70:945-949.
9. Hegele RA, Brunt JB, Connelly PW. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol 1995; 15:89-95.
10. Hegele RA, Connelly PW, Scherer SW, Hanley AJG, Harris SB, Tsui L-C, Zinman B. Paraoxonase-2 G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997a; 82:3373-3377.
11. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997b; 17:1060-1066.
12. Hegele RA, Connelly PW, Scherer SW, Hanley AJG, Harris SB, Tsui L-C, Zinman B. Paraoxonase-2 (PON2) G148 variant in an aboriginal Canadian girl with noninsulin-dependent diabetes mellitus. Lancet 1997c; 350:785.
13. Heinecke JW, Lusis AJ. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis? Am J Hum Genet 1998; 62:20-24.
14. Hill DJ, Hogg J. Growth factors and the regulation of pre-and postnatal growth. Balliere Clin Endocrinol 1989; 3:579-625.
15. Hill WG, Robertson A. Linkage disequilibrium in finite populations. Theor Appl Genet 1968; 38:226-231.
16. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82:402-406.
17. La Du BN, Adkins S, Kuo CL, Lipsig D. Studies on human serum paraoxonase/arylesterase. Chem Biol Interact 1993; 87:25-34.
18. Leger J, Levy-Marchal C, Block J, Pinet A, Chevenne D, Porquet D, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. Brit Med 1997; 315:341-347.
19. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7:69-76.
20. Miller GJ, Beckles GLA, Maude GH, Carson DC, Alexis SD, Price SGL, Byam NTA. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol 1989; 18:808-817.
21. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1 ) is one member of a multigene family. Genomics 1996; 33:498-507.
22. Prochazka M, Thompson B, Scherer SW, Tsui L-C, Knowler WC, Bennett PH, Bogardus C. Linkage and association of insulin resistance and NIDDM with markers at 7q21.3-q22.1 in the Pima Indians. Diabetes 1995; 45:42A.
23. Ramsewak S, Narayansingh G, MacFarlane H. The relationship of a prenatal one-hour plasma glucose screening and risk factors in a mixed population. West Indian Med J 1994; 43:47.
24. Ruiz J, Blanche H, James RW, Garin MC, Vaisse C, Charpentier G, et al. Gin-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346:869-872.
25. Sanghera DK, Saha N, Aston CE, Kamboh MI. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1997; 17:1067-1073.
26. Sanghera DK, Aston CE, Saha N, Kamboh MI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet 1998; 62:36-44.
27. SAS Institute. SAS/STAT Guide for personal computers. Version 6.12, Cary, NC:SAS, 1995.
28. Serrato M, Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995; 36:3005-3008.
29. Shih DM, Gu L, Hama S, Xia Y-R, Navab M, Fogelman AM, Lusis AJ. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest 1996; 97:1630-1639.
30. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394:284-287.
31. Stein CE, Fall CHD, Kumaran K, Osmond C, Cox V, Barker DJP. Fetal growth and coronary heart disease in South India. Lancet 1996; 384:1269-1273.
32. Taylor GO, Albers JJ, Warnick GR, Adolphson JL, McFarlane II, Sullivan DR, et al. Studies of lipoproteins and fatty acids in maternal and cord blood of two racial groups in Trinidad. Lipids 1987; 22:173-177.
33. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995; 96:2882-2891.
34. Watson AD, Leitinger N, Navab M, Faull KF, Harkka S, Witztum JL, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 1997; 272:13597-13607.
35. Williams LA, Evans SF, Newnham JP. Prospective cohort study of factors influencing the relative weights of the placenta and newborn infant. Br Med J 1997; 314:1864-1868.